BBOT
NASDAQ · Biotechnology
Bridgebio Oncology Therapeut
$9.33
+0.55 (+6.26%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+362.0% upside
Low Target
$22.76
Average Target
$43.10
High Target
$48.38
Current Price
$9.33
Current
$9.33
$9.33
Target
$43.10
$43.10
$22.76
$43.10 avg
$48.38
Scenario Analysis
Bear Case
$22.76
143.9%
Low target
Base Case
$43.10
+362.0%
Avg target
Bull Case
$48.38
+418.5%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$14.87
-37.3% from high
52-Week Low
$7.00
+33.3% from low
Target vs 52W High
$43.10
+189.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |